Mapping children by ALT 4-5 years after liver transplant: Potential individual and population applications. Read more about Mapping children by ALT 4-5 years after liver transplant: Potential individual and population applications.
Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group. Read more about Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
Non-operative management of biliary complications after Liver Transplantation in pediatric patients: A 30-year experience. Read more about Non-operative management of biliary complications after Liver Transplantation in pediatric patients: A 30-year experience.
Vitamin D has no impact on outcomes after HSCT in children-A retrospective study. Read more about Vitamin D has no impact on outcomes after HSCT in children-A retrospective study.
Center variation in screening for and management of metabolic syndrome in pediatric liver transplant recipients: A survey of SPLIT centers. Read more about Center variation in screening for and management of metabolic syndrome in pediatric liver transplant recipients: A survey of SPLIT centers.
Transarterial chemoembolization in children to treat unresectable hepatocellular carcinoma. Read more about Transarterial chemoembolization in children to treat unresectable hepatocellular carcinoma.
High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality. Read more about High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
Early bacterial and fungal infection in children receiving allogeneic stem cell transplantation for acute lymphoblastic leukemia in Argentina. Read more about Early bacterial and fungal infection in children receiving allogeneic stem cell transplantation for acute lymphoblastic leukemia in Argentina.
A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency. Read more about A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.
A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency. Read more about A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.
